These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8859258)

  • 1. Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle.
    Köckerling A; Reinalter SC; Seyberth HW
    J Pediatr; 1996 Oct; 129(4):519-28. PubMed ID: 8859258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked reduction of Tamm-Horsfall protein synthesis in hyperprostaglandin E-syndrome.
    Schröter J; Timmermans G; Seyberth HW; Greven J; Bachmann S
    Kidney Int; 1993 Aug; 44(2):401-10. PubMed ID: 8377383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the site of renal tubular defect in Bartter's syndrome.
    Kikuchi M; Sato M; Chiba A; Chiba Y; Nagao K; Suzuki T; Fujigaki Y; Hoshino H
    Acta Paediatr Jpn; 1997 Jun; 39(3):358-61. PubMed ID: 9241901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotyping of hypokalaemic salt-losing tubular disorders.
    Reinalter SC; Jeck N; Peters M; Seyberth HW
    Acta Physiol Scand; 2004 Aug; 181(4):513-21. PubMed ID: 15283765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
    J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furosemide directly stimulates prostaglandin E2 production in the thick ascending limb of Henle's loop.
    Miyanoshita A; Terada M; Endou H
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1155-9. PubMed ID: 2600809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renal tubular defect of Bartter's syndrome.
    Carmine Z; Ettore B; Giuseppe C; Quirino M
    Nephron; 1982; 32(2):140-8. PubMed ID: 7177291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
    Seyberth HW; Schlingmann KP
    Pediatr Nephrol; 2011 Oct; 26(10):1789-802. PubMed ID: 21503667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity.
    Cantone A; Yang X; Yan Q; Giebisch G; Hebert SC; Wang T
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1366-72. PubMed ID: 18385266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do loop diuretics act?
    Wittner M; Di Stefano A; Wangemann P; Greger R
    Drugs; 1991; 41 Suppl 3():1-13. PubMed ID: 1712711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhibitors of prostaglandin synthesis on the furosemide action in the loop Henle of rat kidney.
    Greven J; Farjam A
    Pflugers Arch; 1988 May; 411(5):579-83. PubMed ID: 3164471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle.
    Blanchard A; Jeunemaitre X; Coudol P; Dechaux M; Froissart M; May A; Demontis R; Fournier A; Paillard M; Houillier P
    Kidney Int; 2001 Jun; 59(6):2206-15. PubMed ID: 11380823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal bartter syndrome in an extremely low birth weight baby.
    Hegde D; Mondkar J; Abdagire N
    Saudi J Kidney Dis Transpl; 2017; 28(5):1162-1164. PubMed ID: 28937079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype correlations in normotensive patients with primary renal tubular hypokalemic metabolic alkalosis.
    Bettinelli A; Vezzoli G; Colussi G; Bianchetti MG; Sereni F; Casari G
    J Nephrol; 1998; 11(2):61-9. PubMed ID: 9589375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal reabsorption of Na+/CI- by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman's syndrome.
    Colussi G; Rombolà G; Brunati C; De Ferrari ME
    Am J Nephrol; 1997; 17(2):103-11. PubMed ID: 9096439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distal nephron function in Bartter's syndrome: abnormal conductance to chloride in the cortical collecting tubule?
    Colussi G; Rombolà G; Verde G; Airaghi C; Loli P; Minetti L
    Am J Nephrol; 1992; 12(4):229-39. PubMed ID: 1481870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bartter-Gitelman syndromes].
    Blanchard A; Courand PY; Livrozet M; Vargas-Poussou R
    Nephrol Ther; 2020 Jul; 16(4):233-243. PubMed ID: 32622651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azosemide, a "loop" diuretic, and furosemide.
    Brater DC; Anderson SA; Strowig S
    Clin Pharmacol Ther; 1979 Apr; 25(4):435-9. PubMed ID: 428188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of tubular adaptation to renal sodium loss in Gitelman syndrome.
    Favre GA; Nau V; Kolb I; Vargas-Poussou R; Hannedouche T; Moulin B
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):472-8. PubMed ID: 22241817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.